agilon health, inc. (AGL) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Jay Song, Good afternoon, and thank you for attending the Agilent Health second quarter 2025 conference call. My name is Jay Song. I'll be the moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. I would now like to pass the conference over to your host, Evan Smith. Evan Smith, Thank you, operator. Good afternoon, and welcome to the call. With me are Ron Williams, our executive chair, and our CFO, Jeff Schwanke. Following our prepared remarks, we will conduct a Q&A session. Before we begin, I would like to remind you that our remarks and responses to questions may include forward looking statements. Actual results may differ materially from those stated or implied by forward looking statements due to risks and uncertainties associated with our business. These risks and uncertainties are discussed in our SEC filings. Please note that we assume no obligation to update any forward looking statements. Additionally, Certain financial measures we will discuss in this call are non-GAAP financial measures. We believe that providing these measures helps investors gain a better and more complete understanding of our financial results and is consistent with how management reviews our financial results. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures is available in the earnings press release and form 8K filed with the SEC. And with that, let me turn the call over to Ron. Ron? Thanks, Evan. Good afternoon, everyone, and thank you for joining us on short notice. I'm pleased to be with all of you today. For those of you I may not have met before, I've been chair of Agilon Health since we founded the company. As we announced today, I have been appoint...